On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...